PharmEnable Closes $7.5M Pre-Series Financing

PharmEnable, a Cambridge-based drug discovery company, has closed a $7.5M Pre-Series A funding round led by MP Healthcare Venture Management.

PharmEnable Raises $7.5 Million for Targeted Therapies

PharmEnable is a Cambridge, UK-based drug discovery company focused on chemical novelty, diversity and complexity, discovering targeted therapies with the aim of replicating the specificity of biologics, but with improved efficacy, absorption and distribution properties enabled by custom-designed oral small molecules.

A Cambridge-based drug discovery company discovers targeted therapies with improved efficacy and absorption properties.

2 years ago

PharmEnable Raises $7.5 Million for Targeted Therapies

ProblemHealthcare

Solution

Covered on